HYPERTENSIVE CRISIS IN CARDIOLOGY: PLACE OF URAPIDIL Article Kobalava Zh.D., Kotovskaya Yu.V., Bagmanova N.Kh., Artyukhov O.P., Darmaeva I.P. Kardiologiia. KlinMed Consulting. Vol. 52. 2012. P. 86-90
PERSISTENT DYSLIPIDEMIA IN STATIN-TREATED PATIENTS: RUSSIAN REAL-WORLD CLINICAL PRACTICE DATA (RUSSIAN PART OF THE DYSIS STUDY) Article Oganov R.G., Kukharchuk V.V., Arutyunov G.P., Galyavich A.S., Gurevich V.S., Duplyakov D.V., KarpovYu A., Kobalava Zh D., Konstantinov V.O., Yu M.S., Panov A.V., Sergienko I.V., Skibitskyi V.V., Smolenskaya O.G., Susekov A.V., Tyurin V.P., Shalaev S.V., Maneshina O.A., Brigida O.V. Cardiovascular Therapy and Prevention (Russian Federation). Vserossiiskoe Obshchestvo Kardiologov. Vol. 11. 2012. P. 70-78
FEATURES OF CUTANEOUS ADVERSE DRUG REACTIONS IN INPATIENTS Article Rudyk M.Ya., L.G., Kotovskaya Yu.V., Kobalava Zh.D. Земский врач. 2012. P. 32-33
PREVALENCE AND CLINICAL CHARACTERISTICS AH AT YOUNG MEN Article Safarova A.F., Kotovskaja J.V., Kobalava Zh.D. Земский врач. 2012. P. 30-30
CARBOHYDRATE METABOLISM AND TRANSFORMATION OF PRE-DIABETES INTO TYPE 2 DIABETES MELLITUS DEPENDING ON DIAGNOSTIC METHODS IN NONDIABETIC PATIENTS WITH HYPERTENSION AND HIGH CARDIOVASCULAR RISK Article Tolkacheva V.V., Villevalde S.V., Kobalava ZH.D. Arterial Hypertension (Russian Federation). All-Russian Public Organization Antihypertensive League. Vol. 18. 2012. P. 83-95
ОСТРЫЙ КАРДИОРЕНАЛЬНЫЙ СИНДРОМ У БОЛЬНОГО С ДЕКОМПЕНСАЦИЕЙ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ Article Кобалава Ж.Д, Виллевальде С.В., Клименко А.С., Ефремовцева М.А., Мильто А.С. Клиническая нефрология. Общество с ограниченной ответственностью "Бионика Медиа". 2012. P. 62-68
EFFECTS OF PERINDOPRIL/INDAPAMIDE FIXED HIGH DOSE COMBINATION ON AMBULATORY BLOOD PRESSURE IN SUBJECTS WITH PREVIOUSLY UNCONTROLLED ARTERIAL HYPERTENSION Article Pavlova E.A., Kobalava Zh.D., Kotovskaya Yu.V. Arterial Hypertension (Russian Federation). All-Russian Public Organization Antihypertensive League. Vol. 18. 2012. P. 505-513
НYPERTENSIVE CRISIS IN CARDIOLOGY: PLACE OF URAPIDIL Article Kobalava Zh.D., Kotovskaya Yu.V., Bagmanova N.Kh., Artyukhov O.P., Darmaeva I.P. Kardiologiia. KlinMed Consulting. Vol. 52. 2012. P. 86-90
ВОЗМОЖНОСТИ ПОЛНОДОЗОВЫХ ФИКСИРОВАННЫХ КОМБИНАЦИЙ В ЛЕЧЕНИИ АРТЕРИАЛЬНОЙ ГИПЕРТОНИИ Article Кобалава Ж.Д., Котовская Ю.В., Павлова Е.А. Consilium Medicum. Общество с ограниченной ответственностью Медицинское маркетинговое агентство МедиаМедика. Vol. 14. 2012. P. 5-8
COMPARATIVE EVALUATION OF ARTERIAL STIFFNESS, CENTRAL BLOOD PRESSURE AND PARAMETERS OF BIOIMPEDANCEIN ELDERLY HYPERTENSIVE PATIENTS RECEIVING VALSARTAN IN COMBINATION WITH AMLODIPINE OR S-AMLODIPINE Article Bunjun V., Shkolnikova E., Karaulova Y., Kobalava Zh., Moiseyev V. Клиническая фармакология и терапия. Общество с ограниченной ответственностью "Фармапресс". Vol. 21. 2012. P. 33-38
COMPARATIVE EVALUATION OF THE INFLUENCE OF IVABRADINE AND ATENOLOL ON ARTERIAL WALL STIFFNESS IN PATIENTS WITH STABLE ANGINA AND HYPERTENSION Article Potapenko A., Buravlev M., Shavarov A., Kiyakbayev G., Moiseyev V., Kobalava Zh. Клиническая фармакология и терапия. Общество с ограниченной ответственностью "Фармапресс". Vol. 21. 2012. P. 23-29
F2-ISOPROSTANE IS RELATED TO KIDNEY FUNCTIONAND ARTERIAL RIGIDITY IN PATIENTS WITH UNCOMPLICATED HYPERTENSION Article Kobalava Zh.D., Troshina A.A., Kotovskaya Yu.V., Mirilashvili T.Sh., Milto A.S. Клиническая фармакология и терапия. Общество с ограниченной ответственностью "Фармапресс". Vol. 21. 2012. P. 48-50
LIPID-LOWERING TREATMENT IN PATIENTS WITH CKD:THE RESULTS OF SHARP TRIAL Article Kobalava Zh.D., Villevalde S.V., Milto A.S., Tigay Zh.G. Клиническая фармакология и терапия. Общество с ограниченной ответственностью "Фармапресс". Vol. 21. 2012. P. 12-18
CARDIORENAL SYNDROMES: PATHOGENETIC, CLINICODIAGNOSTIC, PROGNOSTIC AND THERAPEUTIC ASPECTS Article Moiseev V.S., Kobalava Zh.D. Terapevticheskii Arkhiv. Vol. 83. 2011. P. 5-11
EFFECT OF CARVEDILOL AND METOPROLOL CR ADMINISTERED WITH OR WITHOUT ATORVASTATIN ON ELASTIC PROPERTIES OF VASCULAR WALL AND PARAMETERS OF INFLAMMATION IN PATIENTS WITH CHRONIC HEART FAILURE OF ISCHEMIC ORIGIN Article Ozova E.M., Kiyakbaev G.K., Kobalava Zh.D., Moiseev V.S. Kardiologiia. KlinMed Consulting. Vol. 51. 2011. P. 39-46
EFFICACY OF IVABRADIN IN COMBINED TREATMENT OF PATIENTS WITH POSTINFARCTION SYSTOLIC CHRONIC CARDIAC FAILURE Article Potapenko A.V., Abdulazizov O.Sh., Dyachuk L.I., Kiyakbaev G.K., Kobalava Zh.D., Moiseev V.S. Terapevticheskii Arkhiv. Vol. 83. 2011. P. 19-26
STATINS IN PRIMARY PROPHYLAXIS OF CARDIOVASCULAR DISEASES Article Kobalava G.D. Terapevticheskii Arkhiv. Vol. 83. 2011. P. 70-75
VENOUS THROMBOEMBOLISM IN PATIENTS WITH HEART FAILURE Article Averkov O.V., Shevchenko I.V., Mirilashvili T.Sh., Kobalava Zh.D. Cardiovascular Therapy and Prevention (Russian Federation). Vserossiiskoe Obshchestvo Kardiologov. Vol. 10. 2011. P. 101-106
CARDIOVASCULAR RISK FACTORS AND DIABETIC FOOT SYNDROME IN SOUTH INDIAN DIABETIC POPULATION Article RENNIS M.M., SHAVAROVA E.K., KOBALAVA ZH.D. Вестник Российского университета дружбы народов. Серия: Медицина. Федеральное государственное автономное образовательное учреждение высшего образования Российский университет дружбы народов (РУДН). 2011. P. 11-16
THE EFFICACY OF IVABRADIN IN PATIENTS HOSPITALIZED WITH ACUTE CORONARY SYNDROME Article Moiseev V., Dyatchuk L., Potapenko A., Abdulazizov A., Kiyakbaev G., Kobalava Z.H. European Heart Journal. Vol. 32. 2011. P. 731-732
MICROALBUMINURIA IS THE MOST INTEGRATED SIGN OF SUBCLINICAL ORGAN DAMAGE IN UNCOMPLICATED HYPERTENSIVE PATIENTS Article Villevalde S., Milto A., Moiseev V., Kobalava Z. European Heart Journal. Vol. 32. 2011. P. 14-14
NATRIURETIC PEPTIDE INHIBITION IN THE PRESENCE OF ANGIOTENSIN RECEPTOR BLOCKADE FOLLOWING SHORT-TERM TREATMENT WITH LCZ696 IN HEART FAILURE PATIENTS: EFFECT ON ANP, BNP, NT-PROBNP AND CGMP Article Kobalava Z., Averkov O., Meray I., Alexandriya L., Moiseev V., Albrecht D., Feng A., Chandra P., Jordaan P.J. European Heart Journal. Vol. 32. 2011. P. 784-785
A PHASE I SAFETY AND PHARMACOKINETIC STUDY OF EVEROLIMUS, AN ORAL MTOR INHIBITOR, IN SUBJECTS WITH IMPAIRED HEPATIC FUNCTION Article Peveling-Oberhag J., Zeuzem S., Yong W.P., Kunz T., Paquet T., Bouillaud E., Urva S., Anak O., Sellami D., Kobalava Z. EUROPEAN JOURNAL OF CANCER. ELSEVIER SCI LTD. Vol. 47. 2011.
PREVALENCE AND DETERMINANTS OF MASKED INEFFICACY OF ANTIHYPERTENSIVE TREATMENT Article Villevalde S., Kotovskaya Y., Mirilashvili T., Kobalava Z. European Heart Journal. Vol. 32. 2011. P. 427-427
ACHIEVEMENTS AND PROBLEMS OF MODERN TRIALS OF ANTIHYPERTENSIVE DRUGS Article Kobalava Zh.D., Kotovskaya Yu.V. Kardiologiia. KlinMed Consulting. Vol. 51. 2011. P. 91-99